ValuEngine upgraded shares of Express Scripts Holding Company (NASDAQ:ESRX) from a hold rating to a buy rating in a research report sent to investors on Monday morning.

Several other equities research analysts have also recently commented on the company. Jefferies Group LLC set a $72.00 price target on Express Scripts Holding and gave the company a buy rating in a report on Tuesday, August 29th. Needham & Company LLC started coverage on Express Scripts Holding in a research note on Friday, July 21st. They set a hold rating on the stock. Cowen and Company reissued an outperform rating and set a $83.00 price objective on shares of Express Scripts Holding in a research note on Friday, June 9th. Royal Bank Of Canada began coverage on Express Scripts Holding in a report on Tuesday, September 19th. They issued a sector perform rating and a $68.00 target price for the company. Finally, BidaskClub cut Express Scripts Holding from a hold rating to a sell rating in a report on Wednesday, July 12th. Four equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of Hold and a consensus target price of $70.09.

Express Scripts Holding (ESRX) traded up 0.16% during trading on Monday, hitting $63.73. The stock had a trading volume of 244,396 shares. The company has a market cap of $36.81 billion, a PE ratio of 11.06 and a beta of 0.88. Express Scripts Holding has a 12 month low of $57.80 and a 12 month high of $77.50. The company’s 50 day moving average is $62.04 and its 200-day moving average is $62.67.

Express Scripts Holding (NASDAQ:ESRX) last issued its earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.71 by $0.02. The business had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The business’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.57 EPS. On average, equities research analysts predict that Express Scripts Holding will post $6.99 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “Express Scripts Holding Company (ESRX) Upgraded to “Buy” at ValuEngine” was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.watchlistnews.com/express-scripts-holding-company-esrx-upgraded-to-buy-at-valuengine/1605327.html.

In other Express Scripts Holding news, VP Everett Neville sold 1,163 shares of Express Scripts Holding stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $61.48, for a total value of $71,501.24. Following the completion of the transaction, the vice president now directly owns 18,232 shares of the company’s stock, valued at approximately $1,120,903.36. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Woodrow A. Myers, Jr. sold 3,900 shares of Express Scripts Holding stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $63.93, for a total value of $249,327.00. Following the completion of the transaction, the director now directly owns 11,500 shares of the company’s stock, valued at $735,195. The disclosure for this sale can be found here. In the last three months, insiders have sold 5,641 shares of company stock worth $357,317. 0.68% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently modified their holdings of the company. Waldron LP acquired a new position in shares of Express Scripts Holding in the first quarter valued at approximately $206,000. Xact Kapitalforvaltning AB increased its stake in Express Scripts Holding by 2.3% during the 1st quarter. Xact Kapitalforvaltning AB now owns 96,879 shares of the company’s stock worth $6,385,000 after buying an additional 2,197 shares during the period. Pictet Asset Management Ltd. increased its stake in Express Scripts Holding by 1.3% during the 1st quarter. Pictet Asset Management Ltd. now owns 327,168 shares of the company’s stock worth $21,564,000 after buying an additional 4,239 shares during the period. Busey Trust CO increased its stake in Express Scripts Holding by 2.8% during the 1st quarter. Busey Trust CO now owns 107,242 shares of the company’s stock worth $7,069,000 after buying an additional 2,898 shares during the period. Finally, LS Investment Advisors LLC increased its stake in Express Scripts Holding by 7.2% during the 1st quarter. LS Investment Advisors LLC now owns 26,092 shares of the company’s stock worth $1,720,000 after buying an additional 1,747 shares during the period. 88.69% of the stock is currently owned by institutional investors and hedge funds.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.